Department of Medicine, Division of Cardiology, Columbia University Medical Center, and New York-Presbyterian Hospital, New York, New York.
Imaging Institute, Division of Radiology, Cleveland Clinic, Cleveland, Ohio, and Lerner Research Institute, Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio, and Department of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, Ohio, and Philips Healthcare, Cleveland, Ohio.
JACC Cardiovasc Imaging. 2018 Jan;11(1):64-74. doi: 10.1016/j.jcmg.2017.06.006. Epub 2017 Aug 16.
This study sought to determine updated conversion factors (k-factors) that would enable accurate estimation of radiation effective dose (ED) for coronary computed tomography angiography (CTA) and calcium scoring performed on 12 contemporary scanner models and current clinical cardiac protocols and to compare these methods to the standard chest k-factor of 0.014 mSv·mGycm.
Accurate estimation of ED from cardiac CT scans is essential to meaningfully compare the benefits and risks of different cardiac imaging strategies and optimize test and protocol selection. Presently, ED from cardiac CT is generally estimated by multiplying a scanner-reported parameter, the dose-length product, by a k-factor which was determined for noncardiac chest CT, using single-slice scanners and a superseded definition of ED.
Metal-oxide-semiconductor field-effect transistor radiation detectors were positioned in organs of anthropomorphic phantoms, which were scanned using all cardiac protocols, 120 clinical protocols in total, on 12 CT scanners representing the spectrum of scanners from 5 manufacturers (GE, Hitachi, Philips, Siemens, Toshiba). Organ doses were determined for each protocol, and ED was calculated as defined in International Commission on Radiological Protection Publication 103. Effective doses and scanner-reported dose-length products were used to determine k-factors for each scanner model and protocol.
k-Factors averaged 0.026 mSv·mGycm (95% confidence interval: 0.0258 to 0.0266) and ranged between 0.020 and 0.035 mSv·mGycm. The standard chest k-factor underestimates ED by an average of 46%, ranging from 30% to 60%, depending on scanner, mode, and tube potential. Factors were higher for prospective axial versus retrospective helical scan modes, calcium scoring versus coronary CTA, and higher (100 to 120 kV) versus lower (80 kV) tube potential and varied among scanner models (range of average k-factors: 0.0229 to 0.0277 mSv·mGycm).
Cardiac k-factors for all scanners and protocols are considerably higher than the k-factor currently used to estimate ED of cardiac CT studies, suggesting that radiation doses from cardiac CT have been significantly and systematically underestimated. Using cardiac-specific factors can more accurately inform the benefit-risk calculus of cardiac-imaging strategies.
本研究旨在确定更新的转换系数(k 系数),以便准确估计 12 种当代扫描仪型号和当前临床心脏方案进行的冠状动脉计算机断层扫描血管造影(CTA)和钙评分的辐射有效剂量(ED),并将这些方法与胸部标准 k 系数 0.014 mSv·mGycm 进行比较。
准确估计心脏 CT 扫描的 ED 对于有意义地比较不同心脏成像策略的益处和风险以及优化测试和方案选择至关重要。目前,心脏 CT 的 ED 通常通过将扫描仪报告的参数,剂量-长度乘积,乘以 k 系数来估计,该 k 系数是使用单切片扫描仪和已过时的 ED 定义为非心脏胸部 CT 确定的。
金属氧化物半导体场效应晶体管辐射探测器放置在人体模型的器官中,使用所有心脏方案对 12 个 CT 扫描仪进行扫描,共 120 个临床方案,代表来自 5 个制造商(GE、日立、飞利浦、西门子、东芝)的扫描仪范围。为每个方案确定器官剂量,并按照国际辐射防护委员会第 103 号出版物的定义计算 ED。有效剂量和扫描仪报告的剂量-长度乘积用于确定每个扫描仪模型和方案的 k 系数。
k 系数平均为 0.026 mSv·mGycm(95%置信区间:0.0258 至 0.0266),范围在 0.020 至 0.035 mSv·mGycm 之间。标准胸部 k 系数平均低估 ED 46%,范围为 30%至 60%,具体取决于扫描仪、模式和管电压。与回顾性螺旋扫描模式相比,前瞻性轴向扫描模式的系数更高,与冠状动脉 CTA 相比,钙评分的系数更高,与 100 至 120 kV 相比,管电压越低(80 kV)的系数越高,并且在扫描仪模型之间存在差异(平均 k 系数范围:0.0229 至 0.0277 mSv·mGycm)。
所有扫描仪和方案的心脏 k 系数都明显高于目前用于估计心脏 CT 研究 ED 的 k 系数,表明心脏 CT 的辐射剂量已被显著且系统地低估。使用心脏专用系数可以更准确地为心脏成像策略的获益风险计算提供信息。